Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3674309 | 1.00 | CA1 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3679451 | 1.00 | CA1 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3676533 | 1.00 | CA1 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529890 | 0.84 | SMN1; SMN2 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29527801 | 0.78 | CA1 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16694568 | 0.78 | CA1 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL30829086 | 0.76 | CA1 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL6651864 | 0.76 | SMN1; SMN2 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29527648 | 0.76 | SMN1; SMN2 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16449931 | 0.76 | CHRNB4 (0.30) | CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309779-B2 | Ethylene oligomerization catalyst systems having enhanced selectivity | SK INNOVATION CO., LTD. (KR) | 2012-11-13 | — | — | US | disclosed |
| US-20100145124-A1 | ETHEYENE OLIGOMERIZA CATALYST SYSTEMS HAVING ENEHANCED SELECTIVITY | SK INNOVATION CO., LTD. (KR) | 2010-06-10 | — | — | US | disclosed |
| WO-2009022770-A1 | ETHYLENE OLIGOMERIZATION CATALYST SYSTEMS HAVING ENHANCED SELECTIVITY | SK ENERGY CO., LTD. (KR) | 2009-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145124-A1 | ETHEYENE OLIGOMERIZA CATALYST SYSTEMS HAVING ENEHANCED SELECTIVITY | CBR3, ESR2, ESR1 | CA1 3647/4885CA2 2951/4885CA7 4712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.